Inhibition of DNA cytosine methyltransferase by chemopreventive selenium compounds, determined by an improved assay for DNA cytosine methyltransferase and DNA cytosine methylation
The DOI matches its Crossref record.
Abstract
The organoselenium compounds benzyl selenocyanate (BSC) and 1,4-phenylenebis(methylene)selenocyanate (p-XSC), as well as sodium selenite, are effective chemopreventive agents for various chemically induced tumors in animal models at both the initiation and postinitiation stages. The mechanisms involved at the postinitiation stage are not clear. Because several lines of evidence indicate that inhibition of excess DNA (cytosine-5)-methyltransferase (Mtase) may be a sufficient factor for the suppression or reversion of carcinogenesis, we examined the effects of sodium selenite, BSC, p-XSC and benzyl thiocyanate (BTC), the sulfur analog of BSC, on Mtase activity in nuclear extracts of human colon carcinomas, and of p-XSC on the Mtase activity of HCT116 human colon carcinoma cells in culture. For this purpose, we developed an improved Mtase assay, in which the incorporation of the methyl-[3H] group from S-adenosyl[methyl-3H]methionine into deoxycytidine of poly(dI-dC)-poly(dI-dC), is specifically determined by HPLC with radioflow detection after enzymatic hydrolysis, enhancing specificity and reliability. In a variation, using SssI methyltransferase and labeled S-adenosylmethionine, the overall methylation status of DNA in various tissues can also be compared. Selenite, BSC and p-XSC inhibited Mtase extracted from a human colon carcinoma with IC50s of 3.8, 8.1 and 5.2 microM, respectively; BTC had no effect. p-XSC also inhibited the Mtase activity and growth of human colon carcinoma HCT116 cells, with an IC50 of approximately 20 microM. The improved Mtase assay should prove to be a reliable method for screening potential Mtase inhibitors, especially using cells in culture. We suggest that inhibition of Mtase may be a major mechanism of chemoprevention by selenium compounds at the postinitiation stage of carcinogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Organoselenium and Organotellurium Compounds: Toxicology and Pharmacology
Nogueira, C. W., Zeni, G., & Rocha, J. B. T. (2004) · Chemical Reviews · doi:10.1021/cr0406559 · Cited by 1,926
Selenium in cancer prevention: a review of the evidence and mechanism of action
Rayman, M. P. (2005) · Proceedings of the Nutrition Society · doi:10.1079/pns2005467 · Cited by 858
Alegría-Torres, J. A., Baccarelli, A., & Bollati, V. (2011) · Epigenomics · doi:10.2217/epi.11.22 · Cited by 587
Gene-promoter hypermethylation as a biomarker in lung cancer
Belinsky, S. A. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1432 · Cited by 533
DNA Methyltransferase Inhibitors and the Development of Epigenetic Cancer Therapies
Lyko, F., & Brown, R. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji311 · Cited by 510
Toxicology and pharmacology of selenium: emphasis on synthetic organoselenium compounds
Nogueira, C. W., & Rocha, J. B. T. (2011) · Archives of Toxicology · doi:10.1007/s00204-011-0720-3 · Cited by 477
(2002) · PubMed · Cited by 440
Medicinal mushroom modulators of molecular targets as cancer therapeutics
Zaidman, B.-Z., Yassin, M., Mahajna, J., & Wasser, S. P. (2005) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-004-1787-z · Cited by 434
Arsenic and selenium toxicity and their interactive effects in humans
Sun, H.-J., Rathinasabapathi, B., Wu, B., Luo, J., Pu, L.-P., & Ma, L. Q. (2014) · Environment International · doi:10.1016/j.envint.2014.04.019 · Cited by 405
Functional Diversity of DNA Methyltransferase Inhibitors in Human Cancer Cell Lines
Stresemann, C., Brueckner, B., Musch, T., Stopper, H., & Lyko, F. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2821 · Cited by 385
The protective role of selenium on genetic damage and on cancer
El-Bayoumy, K. (2001) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/s0027-5107(01)00075-6 · Cited by 359
Radicais livres e os principais antioxidantes da dieta
Bianchi, M. D. L. P., & Antunes, L. M. G. (1999) · Revista de Nutrição · doi:10.1590/s1415-52731999000200001 · Cited by 310
Selenomethionine regulation of p53 by a ref1-dependent redox mechanism
Seo, Y. R., Kelley, M. R., & Smith, M. L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.212319799 · Cited by 280
Sinha, R., & El-Bayoumy, K. (2004) · Current Cancer Drug Targets · doi:10.2174/1568009043481614 · Cited by 265
Cancer Chemoprevention and Nutri-Epigenetics: State of the Art and Future Challenges
Gerhauser, C. (2012) · Topics in Current Chemistry · doi:10.1007/128_2012_360 · Cited by 194
Selenius, M., Rundlöf, A.-K., Olm, E., Fernandes, A. P., & Björnstedt, M. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2884 · Cited by 170
“Other suggested targets for selenium-mediated prevention include inhibition of carcinogenic biactivation (149), the immune system (67), and cytosine methyltransferase (34).”
Aging, cancer and nutrition: the DNA methylation connection
Liu, L., Wylie, R. C., Andrews, L. G., & Tollefsbol, T. O. (2003) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2003.08.001 · Cited by 167
Metadata
- Authors
- Fiala, E.
- Venue
- Carcinogenesis
- Publisher
- Oxford University Press (OUP)
- Published
- 1998-04-01
- Volume
- 19
- Issue
- 4
- Pages
- 597-604
- ISSN
- 0143-3334 (ISSN-L)
- 1460-2180
- OpenAlex
- W2145099286
- Cited by
- 122
- References
- 0
- FWCI
- 1.46
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.